Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
AstraZeneca
AstraZeneca
Genfleet Therapeutics (Shanghai) Inc.
National Health Research Institutes, Taiwan
Sunshine Lake Pharma Co., Ltd.
Sanofi
Institut Cancerologie de l'Ouest
Zhejiang Cancer Hospital
Fudan University
Fudan University
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
National Cancer Institute (NCI)
Sun Yat-sen University
Taiho Pharmaceutical Co., Ltd.
Hokkaido Gastrointestinal Cancer Study Group
West Japan Thoracic Oncology Group